Les causes chimiques des diverses épidémies de sida








télécharger 0.52 Mb.
titreLes causes chimiques des diverses épidémies de sida
page8/10
date de publication31.03.2017
taille0.52 Mb.
typeDocumentos
b.21-bal.com > droit > Documentos
1   2   3   4   5   6   7   8   9   10
299 1495

Cohen S S 1987 Antiretroviral therapy for AIDS; N. Engl. J. Med. 317 629

Colebunders R, Mann J, Francis H, Bila K, Izaley L, Kakonde N, Kabasele K, Ifoto L, Nzilambi N, Quinn T, van der Groen G, Curran J, Vercauten B and Piot P 1987 Evaluation of a clinical case definition of Acquired Immunodeficiency Syndrome in Africa; Lancet 1 492–494

Colfax G N, Mansergh G, Guzman R, Vittinghoff E, Marks G, Rader M and Buchbinder S 2001 Drug use and sexual risk behavior among gay and bisexual men who attend circuit parties: a venue-based comparison; J. Acquir. Immune. Defic. Syndr. 28 373–379

Connor E M, Sperling R S, Gelber R, Kiselev P, Scott G, O’Sullivan M J, VanDyke R, Bey M, Shearer W, Jacobson R L, Jimenez E, O’Neill E, Bazin B, Delfraissy J-F, Culnane M, Coombs R, Elkins M, Moye J, Stratton P, Balsley J and Pediatric AIDS Clinical Trials Group Protocol 076 Study Group 1994 Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 With Zidovudine Treatment; N. Engl. J. Med. 331 1173–1180

Costello R B (ed.) 1995 Webster’s College Dictionary (New York: Random House)

Craib K J, Weber A C, Cornelisse P G, Martindale S L, Miller M L, Schechter M T, Strathdee S A, Schilder A and Hogg R S 2000 Comparison of sexual behaviors unprotected sex and substance use between two independent cohorts of gay and bisexual men; Aids 14 303–311

Cronkite E P and Bullis J 1990 In vivo toxicity of 3¢-azido-2¢, 3¢-dideoxythymindine (AZT) on CBA/Ca mice; Int. J. Cell Cloning 8 332–345

Curran J, Lawrence D N, Jaffe H, Kaplan J E, Zyla L D, Chamberland M, Weinstein R, Lui K-J, Schonberger L B, Spira T J, Alexander W J, Swinger G, Ammann A, Solomon S, Auerbach D, Mildvan D, Stoneburner R, Jason J M, Haverkos H W and Evatt B L 1984 Acquired immunodeficiency syndrome (AIDS) associated with transfusions; N. Engl. J. Med. 310 69–75

Curran J W, Morgan M W, Hardy A M, Jaffe H W, Darrow W W and Dowdle W R 1985 The epidemiology of AIDS: current status and future prospects; Science 229 1352–1357

Daar E S, Moudgil T, Meyer R D and Ho D D 1991 Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection; N. Engl. J. Med. 324 961–964

Dalakas M C, Illa I, Pezeshkpour G H, Laukaitis J P, Cohen B and Griffin J L 1990 Mitochondrial myopathy caused by long-term zidovudine therapy; N. Engl. J. Med. 322 1098–1105

Darby S C, Ewart D W, Giangrande P L F, Dolin P J, Spooner R J D, Rizza C R and on behalf of the UK Haemophilia Centre Directors’ Organisation 1995 Mortality before and after HIV infection in the complete UK population of haemophiliacs (letter); Nature (London) 377 79–82

Darrow W W, Echenberg D F, Jaffe H W, O’Malley P M, Byers R H, Getchell J P and Curran J W 1987 Risk factors for human immunodeficiency virus (HIV) infections in homosexual men; Am. J. Publ. Health 77 479–483

Day M 2000 No more cocktails; New Scientist, 16 December, p. 7

de Harven E 1999 Viral etiology of human cancer: a historical perspective; Haematologica 84 385–389

de Souza R S, Gomez-Marin O, Scott G B, Guasti S, O’Sullivan M J, Oliveira R H and Mitchell C D 2000 Effect of prenatal zidovudine on disease progression in perinatally HIV-1-infected infants; J. Acquir. Immune Defic. Syndr. 24 154–161

Deeks S G, Smith M, Holodniy M and Kahn J O 1997 HIV-1 protease inhibitors. A review for clinicians; Jama 277 145–153

Diamond C, Thiede H, Perdue T, MacKellar D, Valleroy L A and Corey L 2001 Seroepidemiology of human herpesvirus 8 among young men who have sex with men; Sex Transm. Dis. 28 176–183

Dournon E, Matheron S, Rozenbaum W, Gharakhanian S, Michon C, Girard P M, Perrone C, Salmon D, DeTruchis P, Leport C and the Claude Bernard Hospital AZT Study Group 1988 Effects of zidovudine in 365 consecutive patients with AIDS or AIDS-related complex; Lancet 2 1297–1302

Downs A M, Ancelle R A, Jager H J and Brunet J B 1987 AIDS in Europe: current trends and short-term predictions estimated from surveillance data, January 1981–June 1986; Aids 1 53–57

Duesberg P and Bialy H 1996 Duesberg and the Right of Reply According to Maddox – Nature; in AIDS: Virus- or drug induced? (ed.) P H Duesberg (Dordrecht: Kluwer) pp 111–125

Duesberg P H 1987 Retroviruses as carcinogens and pathogens: expectations and reality; Cancer Res. 47 1199–1220

Duesberg P H 1988 HIV is not the cause of AIDS; Science 241 514–516

Duesberg P H 1992 AIDS acquired by drug consumption and other noncontagious risk factors; Pharmacol. Therapeutics 55 201–277

Duesberg P H 1993a Aetiology of AIDS; Lancet 341 1544

Duesberg P H 1993b HIV and AIDS; Science 260 1705–1706

Duesberg P H 1993c HIV and the aetiology of AIDS; Lancet 341 957–958

Duesberg P H 1993d The HIV gap in national AIDS statistics; Biotechnology 11 955–956

Duesberg P H 1994 Infectious AIDS – stretching the germ theory beyond its limits; Int. Arch. Allergy Immunol. 103 131–142

Duesberg P H 1995a AIDS Data; Science 268 350–351

Duesberg P H 1995b “The Duesberg-Phenomenon”: Duesberg and Other Voices (letter); Science 267 313–314

Duesberg P H 1995c Foreign-protein-mediated immunodeficiency in hemophiliacs with and without HIV; Genetica 95 51–70

Duesberg P H 1995d Is HIV the cause of AIDS? (letter); Lancet 346 1371–1372

Duesberg P H 1996a Commentary: non-HIV hypotheses must be studied more carefully; Br. Med. J. 312 210–211

Duesberg P H 1996b Inventing the AIDS Virus (Washington: Regnery Publishing Inc.)

Duesberg P H and Rasnick D 1998 The AIDS dilemma: drug diseases blamed on a passenger virus; Genetica 104 85–132

Dukers N H, Renwick N, Prins M, Geskus R B, Schulz T F, Weverling G J, Coutinho R A and Goudsmit J 2000 Risk factors for human herpesvirus 8 seropositivity and seroconversion in a cohort of homosexual men; Am. J. Epidemiol. 151 213–224

Durack D T 1981 Opportunistic infections and Kaposi’s sarcoma in homosexual men; N. Engl. J. Med. 305 1465–1467

Eggers H J and Weyer J J 1991 Linkage and independence of AIDS Kaposi disease: The interaction of human immunodeficiency virus and some coagents; Infection 19 115–122

Ellison B J, Downey A B and Duesberg P H. 1996 HIV as a surrogate marker for drug-use: a re-analysis of the San Francisco Men’s Health Study. in AIDS: virus- or drug induced? (ed.) P H Duesberg (Dordrecht, The Netherlands: Kluwer Academic Publishers) pp 97–104

Enserink M 2001 Old guard urges virologists to go back to basics; Science 293 24–25

European Collaborative Study 1991 Children born to women with HIV-1 infection: natural history and risk of transmission; Lancet 337 253–260

Farber C 1998 AZT Roulette; Mothering 90 52–65

Fellay J, Boubaker K, Ledergerber B, Bernasconi E, Furrer H, Battegay M, Hirschel B, Vernazza P, Francioli P, Greub G, Flepp M and Telenti A 2001 Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study; Lancet 358 1322–1327

Fenner F, McAuslan B R, Mims C A, Sambrook J and White D O 1974 The biology of animal viruses (New York: Academic Press)

Fiala C 1998 AIDS in Africa: dirty tricks; NewAfrican April, pp 36–38

Fiala C, de Harven E, Herxheimer A, Kohnlein C, Mhlongo S and Stewart G T 2002 HIV/AIDS data in South Africa; Lancet 359 1782

Fields B 2001 Field’s virology (Philadelphia: Lippincott Williams & Wilkins)

Fischl M A, Richman D D, Grieco M H, Gottlieb M S, Volberding P A, Laskin O L, Leedon J M, Groopman J E, Mildvan D, Schooley R T, Jackson G G, Durack D T, King D and the AZT Collaborative Working Group 1987 The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex; N. Engl. J. Med. 317 185–191

Fischl M A, Richman D D, Causey D M, Grieco M H, Bryson Y, Mildvan D, Laskin O L, Groopman J E, Volberding P A, Schooley R T, Jackson G G, Durack D T, Andrews J C, Nusinoff-Lehrman S, Barry D W and the AZT Collaborative working Group 1989 Prolonged zidovudine therapy in patients with AIDS and advanced AIDS-related complex; Jama 262 2405–2410

Fischl M A, Stanley K, Collier A C, Arduino J M, Stein D S, Feinberg J E, Allan J D, Goldsmith J C and Powderly W G 1995 Combination and monotherapy with zidovudine and zalcitabine in patients with advanced HIV disease. The NIAID AIDS Clinical Trials Group; Ann. Int. Med. 122 24–32

Fogelman I, Lim L, Bassett R, Volberding P, Fischl M A, Stanley K, Cotton D J for the AIDS Clinical Trials Group 1994 Prevalence and patterns of use of concomitant medications among participants in three multicenter human immunodeficiency virus type 1 clinical trials; J. Aquir. Immune Defic. Syndr. 7 1057–1063

France D 2001 The angry prophet is dying: Controversial author Larry Kramer is a one-man history of the AIDS struggle, from early activism to the fading hope of medical salvation; Newsweek June, pp 42–46

Francis D P, Curran J W and Essex M 1983 Epidemic acquired immune deficiency syndrome: Epidemiologic evidence for a

transmissible agent; J. Natl. Cancer Inst. 71 1–4

Fujimura J 1996 Crafting science; a sociohistory of the quest for the genetics of cancer (Cambridge, MA: Harvard University Press)

Gallo R C, Salahuddin S Z, Popovic M, Shearer G M, Kaplan M, Haynes B F, Palker T J, Redfield R, Oleske J, Safai B, White G, Foster P and Markham P D 1984 Frequent detection and isolation of cytopathic retrovirus (HTLV-III) from patients with AIDS and at risk for AIDS; Science 224 500–503

Gellman B 2000 S. African President Escalates AIDS Feud; Washington Post, April 19, p. A01

Gerhard S 2001 Safe and sound underground: HIV-positive women birthing outside the system; Mothering September/October, pp 42–57

Gerschenson M, Erhart S W, Paik C Y, St Claire M C, Nagashima K, Skopets B, Harbaugh S W, Harbaugh J W, Quan W and Poirier M C 2000 Fetal mitochondrial heart and skeletal muscle damage in Erythrocebus patas monkeys exposed in utero to 3¢-azido-3¢-deoxythymidine; AIDS Res. Hum. Retroviruses 16 635–644

Gibbons J 1996 Drugs & Us; Gay Times (London), September, pp 17–37

Gill P S, Rarick M, Byrnes R K, Causey D, Loureiro C and Levine A M 1987 Azidothymidine associated with bone marrow failure in the acquired immunodeficiency syndrome (AIDS); Ann. Int. Med. 107 502–505

Gisselquist D, Rothenberg R, Potterat J and Drucker E 2002 HIV infections in sub-Saharan Africa not explained by sexual or vertical transmission; Int. J. STD AIDS 13 657–666

Goedert J J, Cohen A R, Kessler C M, Eichinger S, Seremetis S V, Rabkin C S, Yellin F J, Rosenberg P S and Aledort L M 1994 Risks of immunodeficiency, AIDS, and death related to purity of factor VIII concentrate; Lancet 344 791–792

Goedert J J, Neuland C Y, Wallen W C, Greene M H, Mann D L, Murray C, Strong D M, Fraumeni J F Jr and Blattner W A 1982 Amyl nitrite may alter T lymphocytes in homosexual men; Lancet 1 412–416

Goodgame R W 1990 AIDS in Uganda-clinical and social features; N. Engl. J. Med. 323 383–389

Gottlieb M S, Schroff R, Schanker H M, Weisman J D, Fan P T, Wolf R A and Saxon A 1981 Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency; N. Engl. J. Med. 305 1425–1431

Grossman S J, Reinfoed N, Eydelloth R S, Alberts D W, Smith P F and Patrick D H 1997 Hepatotoxicity of an HIV protease inhibitor in dogs and rats; Toxicol. Appl. Pharmacol. 146 40–52

Hall C T 1996 AIDS advances boost drugmaker; San Francisco Chronicle, August 1, pp E1–E2

Harper M E, Marselle L M, Gallo R C and Wong-Staal F 1986 Detection of lymphocytes expressing human T-lymphotropic virus type III in lymph nodes and peripheral blood from infected individuals by in situ hybridization; Proc. Natl. Acad. Sci. USA 83 772–776

Haverkos H 1988 Epidemiologic studies – Kaposi’s sarcoma vs. opportunistic infections among homosexual men with AIDS; in Health hazards of nitrite inhalants (eds) H W

Haverkos and J A Doughertry (Rockville, MD: US Department of Health and Human Services, National Institute on Drug Abuse) pp 96–105

Haverkos H W 1996 Is Kaposi sarcoma caused by new herpesvirus?; Biomed. Pharmacother. 50 318–319

Haverkos H W and Dougherty J A (eds) 1988 Health hazards of nitrite inhalants (83 NIDA Research Monograph, US Department of Health and Human Services, Washington DC)

Haverkos H W and Drotman D P 1995 Measuring inhalant nitrite exposure in gay men: implications for elucidating the etiology of AIDS-related Kaposi’s sarcoma; Genetica 95 157–164

Haverkos H W and Drotman D P 1996 NIDA technical review: nitrite inhalants; Biomed. Pharmacother. 50 228–230

Haverkos H W, Drotman D P and Hanson D 1994 Surveillance for AIDS-related Kaposi's sarcoma (KS): update; NIDA/ CDC, Rockville, MD/Atlanta, GA May

Haverkos H W, Pinsky P F, Drotman D P and Bregman D J 1985 Disease manifestation among homosexual men with acquired immunodeficiency syndrome: a possible role of nitrites in Kaposi’s sarcoma; J. Sex. Trans. Dis. 12 203–208

Hazenberg M D, Hamann D, Schuitemaker H and Miedema F 2000 T cell depletion in HIV-1 infection: how CD4+ T cells go out of stock; Nature Immunol. 1 285–289

Hearst N and Hulley S 1988 Preventing the heterosexual spread of AIDS: Are we giving our patients the best advice?; Jama 259 2428–2432

Hendrix A 2002 Artist’s perception stroked by his longtime HIV status; San Francisco Chronicle, March 20

Heredia C 2003a Dance of death, first of three parts: crystal meth fuels HIV; San Francisco Chronicle, May 4, p. A1

Heredia C 2003b Ph D Takes fall to addiction; San Franscisco Chronicle, May 5, p. A1

Heresi G P, Caceres E, Atkins J T, Rueben J and Doyle M 1997 Pneumocystis carinii pneumonia in infants who were exposed to human immunodeficiency virus but were not infected: an exception to the AIDS Surveillance case definition; Clin. Infect. Dis. 25 739–740

Hitchcock M J M 1991 Review: Antiviral portrait series Number 1; 2¢,3¢-Didehydro-2¢,3¢-dideoxythymidine (D4T), an

anti-HIV agent; Antiviral Chem. Chemother. 2 125–132

Ho D D 1995 Time to hit HIV, early and hard; N. Engl. J. Med.
1   2   3   4   5   6   7   8   9   10

similaire:

Les causes chimiques des diverses épidémies de sida iconLa médecine indique que le sida, ayant officiellement causé 28 millions...
Nécessité d’organiser des "fléaux" contre la population noire. En 1931, des tests sont faits secrètement sur les Afro-Américains...

Les causes chimiques des diverses épidémies de sida iconSynthèses chimiques moins nocives
«chimie verte» («green chemistry») a été développé aux États-Unis au début des années 1990 dans le but d'offrir un cadre à la prévention...

Les causes chimiques des diverses épidémies de sida iconI. le sida, les virus concernes, leur pathogenie

Les causes chimiques des diverses épidémies de sida icon1. 2 Classification selon Delay et Deniker, 1957
«designer drugs» ou les drogues de bricolage, substances synthétisé artificiellement dans des laboratoires clandestins à partir des...

Les causes chimiques des diverses épidémies de sida iconProgramme Commun des Nations Unies sur le vih/sida

Les causes chimiques des diverses épidémies de sida iconEditions Christian Pirot
«Bibliothèque de la Pléiade» en douze volumes (CH), ainsi que les deux volumes parus des Œuvres diverses (OD)

Les causes chimiques des diverses épidémies de sida iconLes liaisons chimiques et les interactions moléculaires
Liaisons hydrogènes car ils sont les plus petits et possèdent une fort concentration de charges

Les causes chimiques des diverses épidémies de sida iconPour mieux comprendre le jargon des biologistes… Bio-fiches
«organismes différents vivant ensemble». Cette définition englobe les diverses relations classiquement qualifiées de phorésie, de...

Les causes chimiques des diverses épidémies de sida iconSe propose d’étudier l’intervention du facteur «temps» dans les transformations chimiques

Les causes chimiques des diverses épidémies de sida iconRecherche d'un criterium. Examen des diverses théories transformistes...








Tous droits réservés. Copyright © 2016
contacts
b.21-bal.com